We are live on ! Find out more
BNP Paribas Financial Markets

BNP Paribas Financial Markets Portfolio holdings

AUM $206B
1-Year Est. Return 31.61%
 

BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.

This Fund
S&P 500
This Quarter Est. Return
+11.81%
1 Year Est. Return
+31.61%
3 Year Est. Return
+91.73%
5 Year Est. Return
+103.23%
10 Year Est. Return
+394.96%
AUM
$137B
AUM Growth
-$343M
Cap. Flow
-$60.2B
Cap. Flow %
-43.91%
Top 10 Hldgs %
37.65%
Holding
4,298
New
1,712
Increased
503
Reduced
1,811
Closed
193

Sector Composition

Rank Sector Weight
1 Healthcare 24.44%
2 Technology 23.54%
3 Consumer Discretionary 8.22%
4 Materials 5.85%
5 Real Estate 5.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACW
3601
DELISTED
Accuride Corp
ACW
$2.26K ﹤0.01%
605
-10,683
-95% -$42.2K
BREW
3602
DELISTED
Craft Brew Alliance, Inc.
BREW
$2.25K ﹤0.01%
+137
New +$2.13K
ARTNA icon
3603
Artesian Resources
ARTNA
$362M
$2.25K ﹤0.01%
+98
New +$2.21K
AVEO
3604
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$2.25K ﹤0.01%
122
-1,390
-92% -$27.8K
ENVE
3605
DELISTED
ENVENTIS CORP COM STK
ENVE
$2.25K ﹤0.01%
+175
New +$2.2K
USB icon
3606
CALL
US Bancorp
USB
$100B
$2.24K ﹤0.01%
33
-6,437
-99% -$247K
CYTK icon
3607
Cytokinetics
CYTK
$10.6B
$2.24K ﹤0.01%
+345
New +$2.27K
MCRI icon
3608
Monarch Casino & Resort
MCRI
$2.19B
$2.23K ﹤0.01%
+111
New +$2.08K
RNWK
3609
DELISTED
RealNetworks Inc
RNWK
$2.23K ﹤0.01%
+295
New +$2.32K
OWW
3610
DELISTED
ORBITZ WORLDWIDE, INC
OWW
$2.23K ﹤0.01%
+310
New +$2.42K
HTBK
3611
DELISTED
Heritage Commerce
HTBK
$2.23K ﹤0.01%
+270
New +$2.1K
NEON icon
3612
Neonode
NEON
$16.4M
$2.23K ﹤0.01%
+35
New +$2.04K
CORT icon
3613
Corcept Therapeutics
CORT
$12.1B
$2.22K ﹤0.01%
689
-14,166
-95% -$28.6K
PGC icon
3614
Peapack-Gladstone Financial
PGC
$806M
$2.22K ﹤0.01%
+116
New +$2.12K
GCVRZ
3615
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$2.21K ﹤0.01%
6,499
-80,000
-92% -$96.7K
USLM icon
3616
United States Lime & Minerals
USLM
$3.46B
$2.2K ﹤0.01%
+180
New +$2.06K
NYNY
3617
DELISTED
Empire Resorts, Inc.
NYNY
$2.2K ﹤0.01%
+91
New +$2.11K
KPTI icon
3618
Karyopharm Therapeutics
KPTI
$47.6M
$2.2K ﹤0.01%
+6
New +$1.66K
CPSS icon
3619
Consumer Portfolio Services
CPSS
$198M
$2.2K ﹤0.01%
+234
New +$1.69K
GUID
3620
DELISTED
Guidance Software, Inc.
GUID
$2.19K ﹤0.01%
+217
New +$1.96K
HDNG
3621
DELISTED
Hardinge Inc
HDNG
$2.19K ﹤0.01%
+151
New +$2.24K
HPTX
3622
DELISTED
HYPERION THERAPEUTICS INC COM STK (DE)
HPTX
$2.18K ﹤0.01%
+108
New +$2.54K
TAST
3623
DELISTED
Carrols Restaurant Group, Inc.
TAST
$2.18K ﹤0.01%
+330
New +$2K
CBNJ
3624
DELISTED
CAPE BANCORP, INC COM
CBNJ
$2.16K ﹤0.01%
+213
New +$2.06K
LCUT icon
3625
Lifetime Brands
LCUT
$221M
$2.15K ﹤0.01%
+137
New +$2.07K

Similar funds

BNP Paribas Financial Markets's Q4 2013 Portfolio in Review

As of Q4 2013, BNP Paribas Financial Markets held 4,298 positions worth $137B, down 0.25% from $137B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

BNP Paribas Financial Markets withdrew a net $60.2B in Q4 2013, closing 193 positions and reducing 1,811 holdings. Its most notable exit was Innoviva, an estimated $182M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, BNP Paribas Financial Markets opened a new position in Ambev worth $22.5M.

  • BNP Paribas Financial Markets's largest Q4 2013 buy was Ambev: 3,066,560 shares worth $22.5M.
  • BNP Paribas Financial Markets added most to Apple in Q4 2013, an estimated $156M increase.
  • BNP Paribas Financial Markets's biggest Q4 2013 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.53B.
  • BNP Paribas Financial Markets fully exited Innoviva in Q4 2013, selling an estimated $182M.
  • BNP Paribas Financial Markets's ten largest holdings make up 38% of its $137B portfolio in Q4 2013.
  • BNP Paribas Financial Markets opened 1,712 new positions and closed 193 in Q4 2013.
  • BNP Paribas Financial Markets's portfolio value fell 0.25% quarter-over-quarter to $137B.

Based on BNP Paribas Financial Markets's 13F filing for Q4 2013, filed 12 Feb 2014.